- Home
- DECK vs ELAN Comparison
DECK vs ELAN Comparison
Compare DECK & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DECK | ELAN |
|---|---|---|
| Founded | 1973 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 12.7B |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DECK | ELAN |
|---|---|---|
| Price | $102.15 | $22.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 10 |
| Target Price | ★ $122.45 | $27.89 |
| AVG Volume (30 Days) | 1.4M | ★ 3.8M |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 6.04 | N/A |
| Revenue | ★ $4,985,612,000.00 | $4,715,000,000.00 |
| Revenue This Year | $11.16 | $8.21 |
| Revenue Next Year | $6.96 | $5.31 |
| P/E Ratio | $16.70 | ★ N/A |
| Revenue Growth | ★ 16.28 | 6.22 |
| 52 Week Low | $78.91 | $9.42 |
| 52 Week High | $131.58 | $27.72 |
Technical Indicators
Market Signals| Indicator | DECK | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 43.47 |
| Support Level | $97.94 | $22.17 |
| Resistance Level | $105.32 | $22.89 |
| Average True Range (ATR) | 2.94 | 0.76 |
| MACD | -0.65 | -0.08 |
| Stochastic Oscillator | 15.79 | 26.74 |
Price Performance
Historical ComparisonAbout DECK Deckers Outdoor Corporation
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2025, Ugg and Hoka accounted for 51% and 45% of total sales, respectively. The firm also markets a niche sandal brand called Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores. It generated 64% of its fiscal 2025 sales in the United States.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.